Gastroesophageal reflux disease: A review of surgical decision making
- PMID: 26843915
- PMCID: PMC4724590
- DOI: 10.4240/wjgs.v8.i1.77
Gastroesophageal reflux disease: A review of surgical decision making
Abstract
Gastroesophageal reflux disease (GERD) is a very common disorder with increasing prevalence. It is estimated that up to 20%-25% of Americans experience symptoms of GERD weekly. Excessive reflux of acidic often with alkaline bile salt gastric and duodenal contents results in a multitude of symptoms for the patient including heartburn, regurgitation, cough, and dysphagia. There are also associated complications of GERD including erosive esophagitis, Barrett's esophagus, stricture and adenocarcinoma of the esophagus. While first line treatments for GERD involve mainly lifestyle and non-surgical therapies, surgical interventions have proven to be effective in appropriate circumstances. Anti-reflux operations are aimed at creating an effective barrier to reflux at the gastroesophageal junction and thus attempt to improve physiologic and mechanical issues that may be involved in the pathogenesis of GERD. The decision for surgical intervention in the treatment of GERD, moreover, requires an objective confirmation of the diagnosis. Confirmation is achieved using various preoperative evaluations including: ambulatory pH monitoring, esophageal manometry, upper endoscopy (esophagogastroduodenoscopy) and barium swallow. Upon confirmation of the diagnosis and with appropriate patient criteria met, an anti-reflux operation is a good alternative to prolonged medical therapy. Currently, minimally invasive gastro-esophageal fundoplication is the gold standard for surgical intervention of GERD. Our review outlines the many factors that are involved in surgical decision-making. We will review the prominent features that reflect appropriate anti-reflux surgery and present suggestions that are pertinent to surgical practices, based on evidence-based studies.
Keywords: Decision-making; Fundoplication; Gastroesophageal reflux disease.
Similar articles
-
Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.Dis Esophagus. 2013 Jul;26(5):443-50. doi: 10.1111/j.1442-2050.2012.01381.x. Epub 2012 Aug 2. Dis Esophagus. 2013. PMID: 22862422
-
Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch.Dis Esophagus. 2012 Aug;25(6):498-504. doi: 10.1111/j.1442-2050.2011.01281.x. Epub 2011 Nov 22. Dis Esophagus. 2012. PMID: 22107367
-
Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.J Gastrointest Surg. 1998 Jul-Aug;2(4):333-41. doi: 10.1016/s1091-255x(98)80072-3. J Gastrointest Surg. 1998. PMID: 9841990
-
Diagnosis and treatment of gastroesophageal reflux disease.World J Gastrointest Pharmacol Ther. 2014 Aug 6;5(3):105-12. doi: 10.4292/wjgpt.v5.i3.105. World J Gastrointest Pharmacol Ther. 2014. PMID: 25133039 Free PMC article. Review.
-
Assessment of clinical severity and investigation of uncomplicated gastroesophageal reflux disease and noncardiac angina-like chest pain.Can J Gastroenterol. 1997 Sep;11 Suppl B:37B-40B. Can J Gastroenterol. 1997. PMID: 9347176 Review.
Cited by
-
De novo gastroesophageal reflux disease esophageal surgery in bariatrics: a literature review and analysis of the current treatment options.Ann Transl Med. 2021 May;9(10):899. doi: 10.21037/atm-20-5890. Ann Transl Med. 2021. PMID: 34164533 Free PMC article. Review.
-
Surveillance in Patients With Esophageal Atresia/Tracheoesophageal Fistula.Curr Gastroenterol Rep. 2017 Jan;19(1):4. doi: 10.1007/s11894-017-0541-5. Curr Gastroenterol Rep. 2017. PMID: 28144844 Review.
-
The performance of artificial intelligence large language model-linked chatbots in surgical decision-making for gastroesophageal reflux disease.Surg Endosc. 2024 May;38(5):2320-2330. doi: 10.1007/s00464-024-10807-w. Epub 2024 Apr 17. Surg Endosc. 2024. PMID: 38630178
-
Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: long-term symptomatic follow-up of a prospective randomized controlled trial.Surg Endosc. 2018 Apr;32(4):1668-1674. doi: 10.1007/s00464-017-5845-x. Epub 2017 Oct 18. Surg Endosc. 2018. PMID: 29046957 Clinical Trial.
-
Ineffective Esophageal Motility in Patients with GERD is no Contraindication for Nissen Fundoplication.World J Surg. 2020 Jan;44(1):186-193. doi: 10.1007/s00268-019-05229-y. World J Surg. 2020. PMID: 31605176
References
-
- Herregods TV, Bredenoord AJ, Smout AJ. Pathophysiology of gastroesophageal reflux disease: new understanding in a new era. Neurogastroenterol Motil. 2015;27:1202–1213. - PubMed
-
- Hummel K, Richards W. Endoscopic treatment of gastroesophageal reflux disease. Surg Clin North Am. 2015;95:653–667. - PubMed
-
- Yates RB, Oelschlager BK. Surgical treatment of gastroesophageal reflux disease. Surg Clin North Am. 2015;95:527–553. - PubMed
-
- Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308–328; quiz 329. - PubMed
-
- Kleiman DA, Beninato T, Bosworth BP, Brunaud L, Ciecierega T, Crawford CV, Turner BG, Fahey TJ, Zarnegar R. Early referral for esophageal pH monitoring is more cost-effective than prolonged empiric trials of proton-pump inhibitors for suspected gastroesophageal reflux disease. J Gastrointest Surg. 2014;18:26–33; discussion 33-34. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous